MedPath

Therpeutic drug monitoring of Everolimus in patients with renal cell carcinoma and tuberous sclerosis

Not Applicable
Conditions
1.advanced renal cell carcinoma 2.renal angiomyolipoma associated with tuberous sclerosis complex
Registration Number
JPRN-UMIN000011559
Lead Sponsor
Department of Urology, Keio University School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
43
Inclusion Criteria

Not provided

Exclusion Criteria

Pregnancy Interstitial lung marking in chest imaging Infection Liver dysfunction

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath